Clinical Trial

A Phase 3 Study to Evaluate the Safety and Efficacy of CKD-843 in Male Patients With Androgenetic Alopecia

Name: A Phase 3 Study to Evaluate the Safety and Efficacy of CKD-843 in Male Patients With Androgenetic Alopecia — clinical trial record (NCT06916793)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This is a multi-centers, randomized, double-blind, parallel-group, Phase 3 Trial to evaluate the efficacy and safety of CKD-843 in Male patients with Androgenetic Alopecia

Trial Details

NCT Number	NCT06916793
Lead Sponsor	Chong Kun Dang Pharmaceutical
Conditions	Androgenetic Alopecia
Enrollment	288 participants
Start Date	2025-04-30
Primary Completion	2026-12-19 (estimated)
Study Completion	2027-09-17 (estimated)
Updated on ClinicalTrials.gov	2025-04-08